Targeting immune cells that play a key role in the development of atrial fibrillation (AFib) could give cardiologists a new way to treat the disease, according to a new analysis in Science.[1] The study’s authors said this…

The U.S. Food and Drug Administration (FDA) has announced that Medtronic is recalling nearly 350,000 implantable cardiac devices due to continued issues with their ability to deliver high voltage…

Researchers have developed new heart monitors that dissolve inside the body when they are no longer needed, sharing their work in Science Advances.[1]

The new-look devices are soft, flexible…

The U.S. Food and Drug Administration (FDA) has approved Abbott’s Aveir dual chamber (DR) leadless pacemaker system, the world’s very first dual-chamber leadless pacing solution for treating patients…

Intravascular lithotripsy (IVL) can provide significant value during transvenous lead extraction (TLE) procedures by identifying dense calcifications, according to new research published in JACC: Clinical Electrophysiology.[1…

Adding electrocardiogram (ECG) sensors to shopping carts can helps identify patients who may have atrial fibrillation (AFib) or other…

The U.S. Food and Drug Administration (FDA) recently cleared Abbott's TactiFlex Ablation Catheter, Sensor Enabled, which is the the world's first ablation catheter with a flexible tip and contact force technology. The radiofrequency (RF) catheter…

Post-traumatic stress disorder (PTSD), depression and anxiety are all much more common among patients who receive an implantable cardioverter defibrillator (ICD) than the general population,…

One of the biggest technology trends in cardiac electrophysiology is the the development of pulsed field ablation (PFA), a non-thermal ablation treatment for patients with atrial fibrillation (AF). The Heart…

A patient-administered therapy ear clip device effectively uses nerve stimulation to treat postural tachycardia syndrome (POTS), according to a late-breaking clinical trial at Heart Rhythm 2023 [1]. This may offer a new treatment option for…

The U.S. Food and Drug Administration (FDA) sent a warning letter to iRhythm Technologies detailing several issues related to the company’s Zio AT mobile cardiac telemetry device. The letter was sent…

Conformal Medical, a New Hampshire-based medical device company founded in 2016, has completed a Series D funding round worth $35 million. The new investments come as the company continues developing its…

An artificial intelligence (AI) algorithm that analyses electrocardiograms…